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The Arabidopsis HYPONASTIC LEAVES1 (HYL1) is
a double-stranded RNA-binding protein that forms
a complex with DICER-LIKE1 (DCL1) and SERRATE
to facilitateprocessingof primarymiRNAs intomicro-
RNAs (miRNAs). However, the structural mecha-
nisms of miRNA maturation by this complex are
poorly understood. Here, we present the crystal
structures of double-stranded RNA binding domains
(dsRBD1 and dsRBD2) of HYL1 and HYL1 dsRBD1
(HR1)/dsRNA complex as well as human TRBP2
dsRBD2 (TR2)/dsRNA complex for comparison anal-
ysis. Structural and functional study demonstrates
that both HR1 and TR2 are canonical dsRBDs for
dsRNA binding, whereas HR2 of HYL1 is a non-
canonical dsRBD harboring a putative dimerization
interface. Domain swapping within the context of
HYL1 demonstrates that TR2 can supplant the func-
tion of HR1 in vitro and in vivo. Further biochemical
analyses suggest that HYL1 probably binds to the
miRNA/miRNA* regionofprecursors asadimermedi-
ated by HR2.INTRODUCTION
MicroRNAs (miRNA) have recently emerged to be important
regulators of gene expression through their action on
sequence-specific repression ofmRNA translation and degrada-
tion (reviewed by Siomi and Siomi, 2009). A miRNA gene is
initially transcribed by RNA polymerase II as a long primary tran-
script [primary miRNA (pri-miRNA)], which is subsequently pro-
cessed to precursor miRNA (pre-miRNA) with stem loops; pre-
miRNA is then cleaved into 21 nt mature miRNA by RNase III
family nucleases (reviewed by Jaskiewicz and Filipowicz, 2008;
Ji, 2008). The mature miRNA is loaded into RNA induced
silencing complex to pair with target mRNAs for mRNA cleavage
or translational inhibition (reviewed by Hutva´gner and Simard,
2008; Jinek and Doudna, 2009). Notably, there are significant594 Structure 18, 594–605, May 12, 2010 ª2010 Elsevier Ltd All rightdifferences in first steps in pri-miRNA processing between plants
and animals.
In animal cells, pri-miRNA processing is clearly separated
frompre-miRNA processing in time, components of the process-
ing complex, and their cellular locations. pri-miRNA is first pro-
cessed to pre-miRNA by a complex of two proteins, Drosha,
an RNase III protein, and DIGEORGE SYNDROME CRITICAL
REGION GENE 8 (DGCR8), a dsRNA-binding protein (Han
et al., 2004a, 2006; Landthaler et al., 2004) inside the nucleus.
The resulting pre-miRNA is then cleaved to mature miRNA/
miRNA* duplex by another RNase III protein, Dicer, assisted by
dsRNA-binding proteins (Hutva´gner et al., 2001; Chendrimada
et al., 2005) in the cytoplasm.
Studies in the last few years have uncovered critical roles of
double-stranded RNA-binding proteins in facilitating pri-
miRNA/pre-miRNA processing by RNase III family nucleases in
several organisms (Collins and Cheng, 2005). For example, the
Drosophila Loquacious protein, which contains three tandem
double-stranded RNA binding domains (dsRBDs), works in
concert with DICER1 to convert pre-miRNAs into miRNA/
miRNA* duplexes (Fo¨rstemann et al., 2005; Saito et al., 2005;
Jiang et al., 2005), whereas R2D2 protein, which contains two
tandem dsRBDs, functions along with DICER2 to detect the
differential stability of siRNA duplex ends and determine which
strand enters RNA induced silencing complex (Liu et al., 2003;
Tomari et al., 2004, 2007). The human DGCR8 harboring two
tandem dsRBDs associates with Drosha to convert pri-miRNAs
into pre-miRNAs (Han et al., 2004a, 2006; Landthaler et al.,
2004), whereas TAR (HIV-1) RNA BINDING PROTEIN 2
(TRBP2) harboring three tandem dsRBDs recruits the Dicer
complex to Ago2 for miRNA processing (Chendrimada et al.,
2005). Moreover, the Dicer-TRBP2 complex is sufficient to
process pre-miRNA into miRNA as well as long dsRNA into
siRNA (Chendrimada et al., 2005).
The human DGCR8 is thought to show preferential binding to
the junction between the double-stranded RNA stemportion and
the single-stranded flanking fragment of pri-miRNA. Upon
binding, this protein presumably serves as a molecular ruler to
recruit Drosha for precise cleavage of pri-miRNA 11 bp away
from the junction (Han et al., 2006). Recent crystal structure of
the DGCR8 core domain containing two tandem dsRBDs shows
that it is sufficient to serve as amolecular ruler, although the cores reserved
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Structural insights into miRNA Processing by HYL1domain primarily binds to the dsRNA stem region of pri-miRNA
and does not preferentially recognize the junction (Sohn et al.,
2007).
In plants, both pri-miRNA processing and pre-miRNA pro-
cessing occur inside the nucleus by a complex comprising of
at least three protein subunits: DCL1 (an RNase III protein),
HYL1 (a dsRNA-binding protein), and SERRATE (SE; a zinc-
finger-domain protein). These three proteins are all required
for the maturation of miRNA/miRNA* duplexes from plant pri-
miRNAs (Grigg et al., 2005; Kurihara et al., 2006; Lobbes
et al., 2006; Dong et al., 2008). As in animal cells where
dsRNA-binding protein DGCR8 and TRBP2 are essential
factors for miRNA processing, the Arabidopsis dsRNA-binding
protein HYL1 plays a critical role in assisting DCL1 in the
precise processing of miRNAs from pri-miRNAs (Kurihara
et al., 2006). HYL1 contains two tandem dsRBDs, a putative
nuclear localization signal at its N terminus and a putative
protein-protein interaction domain at its C terminus (Lu and Fe-
doroff, 2000; Han et al., 2004b). The HYL1 C-terminal domain
appears to be dispensable for function and the N-terminal
region containing the two tandem dsRBDs alone is sufficient
to completely rescue the hyl1-2 phenotype (Wu et al., 2007).
In vitro miRNA processing assays using recombinant DCL1,
HYL1, and SE demonstrated that both HYL1 and SE are func-
tional components of a complex that are required for precise
and efficient processing of miRNAs from pri-miRNAs (Dong
et al., 2008).
Because the N-terminal HYL1 fragment comprising two
tandem dsRBDs can facilitate pri-miRNA cleavage by DCL1, it
is reasonable to assume that dsRNA binding proteins may
possess a general mechanism to recognize pri-miRNA and
present the latter for cleavage by RNase III enzymes. To investi-
gate the structural basis for miRNA precursor recognition, we
have determined the crystal structures of individual HYL1 dsRBD
domains (dsRBD1or HR1 and dsRBD2 or HR2) and HR1/dsRNA
complex as well as human TRBP2 RBD2/dsRNA (TR2/dsRNA)
complex for comparative analysis.
Analysis by electrophoretic mobility shift assays (EMSA)
demonstrated that HR1 as well as TR2 possess high dsRNA
binding affinity, which is greatly reduced in HR2. Consistent
with the EMSA results, domain swapping experiments showed
that TR2 is capable of replacing HR1 both in vitro and in vivo:
TR2+HR2 chimeric protein has similar pri-miRNA binding affinity
in vitro compared with HR1+2 and the TR2+HR2 chimeric
protein is able to rescue the hyl1-2 mutant phenotype in vivo.
Notably, from the crystal structure we found HR2 harbors a puta-
tive dimerization interface. The dimerization of HYL1 was further
confirmed by in vitro pull-down, coimmunoprecipitation, and
analytical gel filtration assays.
On the basis of these structural, biochemical, and in vivo anal-
yses, we propose a hypothetical model for HYL1/dsRNA interac-
tion. Our model suggests that HR1 and HR2 may function coop-
eratively for dsRNA binding, whereas HR2 may further mediate
HYL1 dimerization to strengthen dsRNA binding affinity and
enable HYL1 to scan along pri-miRNA/pre-miRNA to preferen-
tially recognize the miRNA/miRNA* region or thermodynamically
stable stem region of pri-miRNA. Working together with SE, HYL
probably serves as a molecular ruler to facilitate precise and
efficient miRNA processing by DCL1.Structure 18,RESULTS
Crystal Structures of Double-Stranded RNA Binding
Domains
To investigate the structural principles for recognition of miRNA
precursors by Arabidopsis HYL1, we have screened hundreds of
cocrystallization conditions of HYL1 and its fragments with
a series of RNA duplexes of different lengths. At the end, we
were able to crystallize and determine the crystal structures of
individual dsRBDs of HYL1 (HR1 and HR2) and of HR1/dsRNA
complex (two 10 bp dsRNA stacked collinearly) (Figure 1A).
For comparative purpose we also determined the crystal struc-
ture of the human TR2/dsRNA complex (two 10 bp dsRNA
stacked collinearly). All these structures were determined by
molecular replacement using the crystal structure of the second
dsRBD of Xenopus laevis RNA-binding protein A as the search
model (PDBID: 1DI2). The latter was cocrystallized with the
similar 10 bp RNA duplex, which we used for cocrystallizations
of HR1 and TR2 (Ryter and Schultz, 1998). Crystallographic
statistics are summarized in Table 1.
Like other dsRBDs (reviewed by Doyle and Jantsch, 2002),
HR1, HR2, and TR2 are approximately 70 amino acids in length
and share the similar overall fold with a common a-b-b-b-a struc-
ture in which the two a helices lie on the surface of a three-
stranded anti-parallel b sheet (Figure 1B; see Figure S1 available
online). Comparison of crystal structures of the dsRBDs with the
search model Xenopus laevis dsRBD2 shows that HR1, HR2,
and TR2 have rmsd values of 3.046 A˚, 3.033 A˚, and 0.658 A˚
(68 Ca atoms), respectively (Figure 1C). Therefore, the structures
of TR2 are much closer to those of Xenopus laevis dsRBD2,
which binds to the dsRNA (Ryter and Schultz, 1998). Although
HR1 and HR2 have a similar fold with an rmsd value of 2.865 A˚
(68 Ca atoms), there are significant structural deviations
between them at the putative RNA binding surfaces. HR1 has
close structural similarities with the human TR2 and Xenopus
laevis dsRBD2 in these regions, including region 2, which
contains the invariable histidine residue (Figure 1B). In contrast,
HR2 has less structural similarity in these regions, including
the different loop orientation at region 2 and an 3.5 A˚ helix
movement toward the potentially bound dsRNA in region 1
(Figure 1C). Since neither the loop at region 2 nor the a helix at
region 1 is heavily involved in protein-protein packing in the
crystal, the significant structural deviation of HR2 from other
consensus dsRBD at the putative dsRNA binding surface
(Figure 1D) strongly suggests that HR2 is unable to bind canon-
ical dsRNA.
DsRNA Binding Surface versus Dimerization Interface
Comparison of crystal structures of HR1/dsRNA complex and
TR2/dsRNA complex with the crystal structure of Xenopus laevis
dsRBD2/dsRNA complex reveals a conserved dsRNA binding
surface with a similar electrostatic potential charge distribution
(Figures 2A, 2C, and 2D). All these canonical dsRBDs share
a conserved positive electrostatic potential charge in region 3,
which is involved in recognizing the major groove of dsRNA.
Similar neutral or slightly negative electrostatic potential
surfaces in region 1 and region 2, together with a small patch
of a positive electrostatic potential surface in region 2, which
contains the invariable histidine residue, specifically recognize594–605, May 12, 2010 ª2010 Elsevier Ltd All rights reserved 595
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Figure 1. Domain Architecture, Sequence Alignment, and Overall Structure of and Structural Comparison of Different dsRBDs
(A) Schematic of the dsRBD domain borders in Arabidopsis HYL1.
(B) Sequence alignment and secondary structures of four different dsRBDs. The aligned sequences are in the order of HR1, HR2, TRBP2 dsRBD2 (TR2), and
XLRBPA dsRBD2 (XR2). The secondary structure diagram for dsRBD is shown on the top. The a helices are colored in yellow and b strands in green. Conserved
residues are shaded in cyan (80% conservation) and green (60% conservation), whereas essentially invariant residues are shaded in yellow. The invariable histi-
dine residues within canonical dsRBDs are highlighted by a red rectangle and three regions involved in dsRNA recognition are indicated.
(C and D) Significant secondary structural differences between HR2 (green) and other dsRBDs. Note the different orientation of the recognition loop in region 2
and 3.5 A˚ movement toward the putative bound dsRNA at region 1 (C), which disrupts the dsRNA binding (D). HR1 is shown in blue, HR2 in green, TR2 in
magenta, and XR2 in pink.
Structure
Structural insights into miRNA Processing by HYL1the dsRNA minor groove. These canonical dsRBDs recognize
two successive minor grooves and the intervening major groove
within an RNA duplex with a total of 16 bp in length formed by
two stacking GC-rich dsRNA (Figures 2A, 2C, and 2D).
To determine whether the conserved residues observed in the
interaction with dsRNA play a primary role in dsRNA binding, we
introduced point mutations on the conserved residues H43
(region 2) and R67 (region 3) to yield HYL1 H43A and HYL1
R67A mutants. EMSA analysis showed that both HYL1 H43A
and HYL1 R67A mutants displayed only slightly decreased
dsRNA binding affinity, whereas the negative control mutants,
HYL1 R19A, HYL1 R19K, and HYL1 Q21A, showed similar
dsRNA binding affinity compared to the wild-type (WT) HYL1
(Figure S2). The marginal decrease in binding affinity observed
with HYL1 mutants is not surprising since we found that canon-596 Structure 18, 594–605, May 12, 2010 ª2010 Elsevier Ltd All rightical dsRBDs interact extensively with dsRNA. This notion is
consistent with the recent report that multiple mutations on the
DGCR8 core had no detectable effect on dsRNA binding affinity
(Sohn et al., 2007). Interestingly, point mutations at the third
dsRBD domain of Drosophila staufen lead a significant decrease
of dsRNA binding affinity, probably due to the unique RNA stem
loop binding mode exhibited by this dsRBD domain (Ramos
et al., 2000).
In contrast, comparison of HR2 with HR1 reveals significant
structural differences at the putative dsRNA binding regions 2
and 3 of HR2. HR2 contains a somehow different orientation of
the loop at region 2with the conserved histidine residue forminor
groove recognition being replaced by an arginine residue
(Figures 1B and 1C). The non-canonical HR2 has a significantly
different electrostatic potential surface in region 2, with a bigs reserved
Table 1. Data Collection and Refinement Statistics
HYL1
dsRBD1
HYL1
dsRBD1/
dsRNA
HYL1
dsRBD2
TRBP2
dsRBD2/
dsRNA
PDBID 3ADG 3ADI 3ADJ 3ADL
Space group P212121 P43 P43 I212121
Cell dimensions
a (A˚) 36.39 47.62 46.11 55.30
b (A˚) 37.90 47.62 46.11 60.43
c (A˚) 51.26 115.38 33.32 99.89
Protein
molecules/ASU
1 3 1 1
Wavelength (A˚) 1.54 1.54 1.54 1.10
Resolution (A˚)a 1.7 3.2 3.0 2.2
Rsym (%)
a 3.2 (18.2) 10.1 (46.7) 5.6 (25.0) 4.6 (29.3)
I/s(I) 40.0 (9.0) 19.9 (4.7) 38.6 (8.1) 54.0 (10.1)
Completeness (%)a 98.4 (97.4) 97.9 (97.5) 99.7 (97.9) 99.1 (98.1)
Redundancy 5.7 7.7 7.0 14.4
Resolution (A˚) 1.7 3.2 3.0 2.2
No. reflections 7709 3783 1322 8276
Rwork (Rfree) (%) 20.7 (25.4) 20.4 (31.7) 25.5 (32.2) 26.1 (29.8)
No. atoms
Protein 579 1,716 547 596
Ligand/ion 422 430
Water 124 5 47
B factors (A˚2)
Protein 30.22 69.66 30.80 48.24
Ligand/ion 60.70 45.07
Water 34.86 41.35 59.28
Rmsd
Bond lengths (A˚) 0.016 0.011 0.017 0.012
Bond angles () 1.376 1.619 1.627 1.492
a Values for the highest-resolution shell are in parentheses.
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Structural insights into miRNA Processing by HYL1patch of strong negatively charged surface adjacent to a patch of
positively charged surface (Figure 2B). There is also a distinct
difference in the surface shape of region 2 of HR2. Canonical
dsRBDs have two protruding edges in region 2 for dsRNA recog-
nition, whereas HR2 has no such protruding edge in the same
region (Figures 2A, 2C, and 2D). The charge and shape differ-
ences as well as the change at the conserved histidine residue
in region 2 render HR2 unlikely to bind to a canonical dsRNA.
On the other hand, the partially merged positively charged
surface in regions 2 and 3 provides an extended positively
charged surface for HR2 to potentially recognize partner
proteins bearing negatively charge surfaces. The significant
deviation of the potential charge and surface shape of the puta-
tive dsRNA binding surface of HR2 suggests that this surface
may mediate protein-protein interaction rather than dsRNA
binding (Figure 2B). Indeed, our structural analysis of HR2
domain uncovers a putative dimerization interface. This dimer-
ization interface is primarily formed between the b1 strand of
one HYL1 dsRBD2 molecule and the b30 strand of its symmetric
related molecule in a parallel interaction mode, whereas theStructure 18,C-terminal a20 from the symmetric related molecule resides on
the top of the b sheet formed by b1 and b2 (Figure 2E). The
dimerization interface buries 1,460 A˚2 of the total solvent-
accessible area per molecule with perfectly complementary
electrostatic potential interactions (Figures 2B and 2F), suggest-
ing that this dimerization interface has biological significance
and is not an artifact of crystal packing. Our structural observa-
tion is consistent with the report that many non-canonical
dsRBDs are able to form a homodimer independently of the
presence of dsRNA (Doyle and Jantsch, 2002).
Next, we testedwhether pointmutations at the dimeric surface
of HR2 can disrupt HR2 dimerization. To this end, wemade eight
triple mutants, namely, Y120A/Q121A/C122A, L128A/G129A/
R130A, K144A/Y145A/T146A, and T152A/K153A/K154A, within
the context of HR1+2 or HR2, respectively. However, all of these
triple mutants yield misfolded proteins or no protein expression
at all. Hence, in spite of extensive efforts, we failed to generate
mutations at the putative dimerization interface, which can
significantly disrupt dimerization without changing the overall
fold of HR1+2 or HR2.
HYL1 Has No Binding Preference for miRNA Precursors
Other Than miRNA/miRNA* Duplex
To investigate the molecular mechanism for miRNA precursors
binding by HYL1, we constructed cDNAs encoding full-length
HYL1 and a series of HYL1 deletion mutants for in vitro RNA
binding assays using pri-miRNA, pre-miRNA, and siRNA
duplexes as substrates. Figure 3A shows that full-length HYL1
was able to interact with in vitro transcribed pri-miR164b to
form a stable HYL1-RNA complex and the amount of protein-
RNA complex increased with increasing amounts of HYL1
protein. This result is consistent with the recent report that
HYL1 is able to pull down miRNA precursors by immunoprecip-
itation (Song et al., 2007). Furthermore, the stable HYL1-pri-
miR164b complex can be competed by either pre-miR164b or
21-nt (19 bp duplex) miR164b/*, suggesting that HYL1 has no
apparent binding preference for miRNA precursors other than
miRNA/miRNA* duplex (Figure 3A, left). Because pri-miRNAs,
pre-miRNAs, and miRNAs/* duplexes are produced by sequen-
tial steps of the miRNA biogenesis pathway, the ability of HYL1
to bind to all these RNAs may suggest that HYL1 possibly
participates in several sequential steps during miRNA process-
ing and maturation.
To further investigate functional roles of individual dsRBD
domains of HYL1 and confirm our structural findings that HR1
is a canonical dsRBD whereas HR2 is a non-canonical dsRBD,
we performed EMSA on HYL1 and HR1 and HR2 using pre-
miR164b as an RNA substrate (Figure 3A, right). HR1 displayed
low binding affinity with pre-miR164b compared with full-length
HYL1, HYL1 core (HR1+2), and HYL1 core extension (HR1+2+H)
in spite of the fact that HR1 is the only canonical dsRNA binding
domain within the protein. In contrast, HR2 displays very weak
binding affinity with pre-miR164b. Using EMSA, we estimated
that full-length HYL1 displayed a 40-fold higher binding affinity
than HR1 for dsRNA (Figure S3A), which suggests that HR1 is
necessary for dsRNA interaction but insufficient for high binding
affinity. This surprising difference of dsRNA binding affinity
between full-length HYL1 and HR1 also suggests that HR2
may be involved in dsRNA binding enhancement.594–605, May 12, 2010 ª2010 Elsevier Ltd All rights reserved 597
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Figure 2. DsRNA or Protein Binding
Surfaces of Individual dsRBDs
(A–D) Electrostatic potential views of individual
dsRBDs bound to dsRNA or partner protein.
Note that HR1 (A), TR2 (C), and XR2 (D) are
canonical dsRNA binding domains with the
bound dsRNA being recognized by two pro-
truding edges, whereas HR2 is a non-canonical
dsRNA binding domain with the partner protein
being recognized by the elongated positive elec-
trostatic potential charged surface. Individual
dsRBDs are represented as electrostatic potential
view and bound dsRNA and protein partner are
represented as ribbon view with the blue, red,
and white colors representing the positive, nega-
tive, and neutral charge, respectively. The pro-
truding edges for dsRNA recognition and the elon-
gated positive charged surface are indicated.
Three regions involved in dsRNA recognition are
also shown.
(E) Ribbon representation of HR2 dimer. The
dimerization interface is primarily formed between
the b1 strand of one HR2 molecule and the b30
strand of its partner molecule in a parallel interac-
tion mode, whereas the C-terminal a20 from the
partner molecule is located on top of the b sheets
formed by b1 and b2.
(F) Electrostatic potential charge representation of
HR2 dimer with the same orientation as in (B). The
dimerization interface buries 1460 A˚2 of total
solvent-accessible area per molecule with
perfectly complementary electrostatic potential
interactions.
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Structural insights into miRNA Processing by HYL1HYL1 Probably Recognizes the Configuration of dsRNA
Secondary Structure
Plant pri-miRNAs have various lengths of stem and loop struc-
tures with the 21 bp miRNA/miRNA*s embedded within the
folded pre-miRNAs. The distinct binding affinity between HYL1
and pre-miRNAs raised the question how HYL1 distinguishes
the miRNA/miRNA* region from the non-miRNA duplex regions
within a folded pre-miRNA. Because HYL1 did not exhibit appar-
ently sequence-specific dsRNA binding (data not shown), we
speculated that secondary structures of dsRNAs might deter-
mine HYL1-dsRNA interaction. To investigate this hypothesis,
we conducted EMSA using four non-miRNA 21 nt (19 bp)
duplexes from proximal regions of miR160/* or miR164/*
(Figure S4 and Table S2). Our EMSA data showed that 21 nt
(19 bp) duplexes from proximal regions of miR160/* or
miR164/* in miRNA precursors displayed reduced HYL1 binding
affinity, although these duplexes possess similar dsRNA lengths
as those of miR160/* or miR164/* (Figure 3B, top panel, with the
secondary structure shown at Figure 3C). The situation was also
applied to HYL1 core domain (HR1+2) (Figure 3B, bottom).
Taken together, these results suggest that configuration of
dsRNA secondary structure is probably an important determi-
nant for HYL1/dsRNA interaction mediated by HR1+2 core598 Structure 18, 594–605, May 12, 2010 ª2010 Elsevier Ltd All rightdomain, consistent with the structural findings that canonical
dsRBDs have the preference to bind to the standard RNA
duplexes without significant bending (Figures 2A and 2C).
TR2+HR2 Chimeric Protein Can Replace HR1+2 Core
Domain In Vitro and In Vivo
Our biochemical analysis showed that HR1+2 core domain plays
an important role in the maturation of miRNA from precursors by
recognizing the miRNA/miRNA* region in a sequence-indepen-
dent mode. If HR1+2 core domain can indeed participate in dis-
tinguishing the miRNA/miRNA* region within precursors through
scanning of the secondary structure of miRNA/miRNA*, its func-
tion may be supplanted by other dsRNA-binding domains
comprising a similar domain arrangement. To this end, we tested
whether TR2 can replace HR1 in the context of HYL1 to
fulfill HYL1 biological functions both in vitro and in vivo given
the closely structural and functional similarities between TR2
and HR1 (Figures 2A and 2C) (Daviet et al., 2000). As expected,
chimeric TR2+HR2 and HR1+2 bind to miR160/* with similar
high affinity (Kd = 7.8 ± 0.52 3 10
8 M versus Kd = 7.6 ±
0.48 3 108 M) (Figure 4A; Figure S3B), which suggests that
the TR2 domain is able to functionally supplant the HR1 domain
in miRNA/miRNA* binding in vitro.s reserved
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Figure 3. Gel Mobility Shift Assay of HYL1
with Pri-miRNA, Pre-miRNA, 21 nt (19 bp
Duplex) miRNA/miRNA*, and Non-miRNA/
miRNA* Duplexes
(A) (Left) Interaction of HYL1 with pri-miRNA. Full-
length HYL1 was added to each reaction in the
indicated amounts (0–2 3 108 M). Lanes 1–3,
2 3 108 M of 32P-labeled pri-miRNA164b was
used as probe; lanes 4–6, same as lane 3 but
with increasing amounts of unlabelled pre-
miRNA164b; lanes 7–9, same as lane 3 but
with increasing amounts of unlabelled 21 nt
(19 bp duplex) miRNA164/*. (Right) Interaction
of HYL1 with pre-miRNA. Varying amounts
(HYL1, 2 3 108 M; HR1+2+H, 2 3 108 M;
HR1+2, 2 3 108 M; HR1, 2 3 107 M; HR2,
23 106 M) of HYL1 deletion mutants were added
to each reaction with 2 3 108M of 32P-labeled
pre-miRNA164b.
(B) Interaction of HYL1 with non-miRNA
sequences in the stem and loop regions of miRNA
precursors. (Top) Full-length HYL1 protein (2 3
108 M) was incubated with four different non-
miRNA duplex probes (2 3 108 M): 21 nt
miR160/* shift-1, 21 nt miR160/* shift-2, 21 nt
miR164/* shift-1, and 21nt miR164/* shift-2. These
probes contain more internal loops, unpaired
bases, and mismatches compared with
miRNA160/* or miR164/*. MiR172/* and miR869/*
were used as positive controls. (Bottom) HR1+2
core domain of HYL1 protein (4 3 108 M) was
incubated with four different non-miRNA duplex
probes (2 3 108 M).
(C) Secondary structures of non-miRNA/miRNA*,
miR160/miR160*, and miR164/miR164* duplexes
used in gel mobility shift assays.
Structure
Structural insights into miRNA Processing by HYL1Since chimeric TR2+HR2 efficiently bound to duplex miR160/*
with an affinity similar to that of HR1+2, we generated transgenic
lines in the hyl1-2mutant background to assess the in vivo func-
tion of TR2+HR2. Consistent with its in vitro activity, chimeric
TR2+HR2 can rescue the miRNA-deficient phenotype of the
hyl1-2 mutant to a large extent (Figures 4B and 4C). Typical
phenotypes of hyl1-2 such as upward curling leaf shape, rela-
tively small plant size, small curled silique, and abnormal influor-
escence and flowers were relatively complemented to WT-like
phenotypes by expression of TR2+HR2. Along with the recovery
of WT morphology, miRNA deficiencies and target mRNA levels
of hyl1-2 mutant were also restored to close to WT expression
levels (Figures 4D and 4E). These molecular and morphological
results support the notion that TR2+HR2 can largely restore
HYL1 deficiency in the hyl1-2mutant background and its activity
is comparable to that of HR1+2 (Wu et al., 2007).
To investigate whether chimeric TR2+HR2 also has the same
function as HR1+2 in upstream miRNA processing, we con-Structure 18, 594–605, May 12, 2010ducted coimmunoprecipitation of miRNA
precursor using anti-HYL1 antibody.
Indeed, miR164b and miR172a precur-
sors were detected from the extract
prepared from chimeric TR2+HR2-
rescued hyl1-2 in immunocomplexes,
whereas no miRNA precursors werefound in extract prepared from hyl1-2. Similar experiments using
WT (Col-0) and se-1 and dcl1-9 mutant plants showed that pre-
miRNA binding to HYL1 did not require SE or DCL1 (Figure 4F).
HYL1 May Recognize 21nt dsRNA as a Dimer
As the exact size of HYL1-dsRNA complexes could not be in-
ferred by in vitro pull-down assays and in vivo immunoprecipita-
tion, we attempted to determine the size of the complex by gel
filtration. Freshly purified full-length HYL1 is monomeric but mul-
timerization occurred after prolonged incubation of the protein
without 21 nt dsRNA (Figure 5A). The spontaneously formedmul-
timeric protein complexes are around 440 kDa, equal to eight to
ten molecules of HYL1, whereas the HYL1 monomer peak is
observed between 67 kDa and 43 kDa, consistent with the ex-
pected size (46 kDa) of the protein. A short incubation of HYL1
with 21 nt dsRNA shifted 90% of the HYL1 monomer peak to
a peak of 110 kDa (Figure 5B), corresponding approximately to
the combined mass of two HYL1 and one 21 nt dsRNAª2010 Elsevier Ltd All rights reserved 599
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Figure 4. TR2 Can Substitute for HR1 In Vivo
and In Vitro
(A) Interaction of HR1+2 and TR2+HR2 with
miRNA160/* duplex. (Left) Schematic diagrams
of HR1+2 and TR2+HR2 chimeric proteins.
Black box represents HR1; gray boxes, HR2; and
striped box, TR2. (Right) Gel mobility shift assay
of HR1+2 and TR2+HR2. Equal amounts of HYL1
deletion mutant (HR1+2, 23 108 M) and chimeric
protein (TR2+HR2, 2 3 108 M) were mixed with
2 3 108 M of 21 nt (19 bp duplex) miRNA160/*.
HR1+2 and chimeric TR2+HR2 display similar
binding affinity.
(B) Overexpression of chimeric protein TR2+HR2
or HR1+2 can rescue the miRNA-deficient pheno-
type of the hyl1-2 mutant. Morphology of trans-
genic lines overexpressing 35-6myc-HR1+2 and
35S-3HA-TR2+HR2 transgenes. Seedlings were
grown on soil for 20 days under long day condition.
(C) Protein levels of overexpressed HYL1
dsRBD1+2-6myc and 3HA-TRBPD2+HYL1
dsRBD2. Levels of endogenous HYL1 and trans-
gene products were determined with anti-HYL1
antibody. Tubulin levels were used as a loading
control.
(D) Restoration of miRNA levels in hyl1-2 mutant
plants overexpressing 35-6myc-HR1+2 and 35S-
3HA-TR2+HR2 transgenes. miRNA levels in trans-
genic lines hyl1-2 and WT were analyzed by
northern blots. Each lane contained 10 mg of total
RNAs. Blots were hybridized to DNA complemen-
tary to miRNA159, miRNA160, miRNA164,
miRNA166, and miRNA172. 5SRNA/tRNA were
used as a loading control.
(E) Levels of target gene transcripts and pri-miR-
NAs were analyzed by quantitative RT-PCR.
Results were normalized with respect to ACTIN
transcript levels. Average results of three repli-
cates are given along with standard errors.
(F) Detection of miRNA precursors in immunocom-
plex of HYL1 and/or TR2+HR2. Crude extracts
were prepared from WT (Col-0), se1, dcl1-9, and
hyl1-2 plants and hyl1-2/35S-3HA-TR2+HR2
transgenic plants. Immunoprecipitations were per-
formed using anti-HYL1 antibody. RNAs in immu-
nocomplex were amplified by PCR using primer
pairs to detect miRNA precursors.
Structure
Structural insights into miRNA Processing by HYL1(Figure 5C). Determination of the dsRNA amount in the shifted
peak gave a HYL1/dsRNA ratio of 2:1, which is consistent with
the isothermal titration calorimetry assay (ITC) showing that
21 nt (19 bp duplex) dsRNA harbors two HYL1 binding sites600 Structure 18, 594–605, May 12, 2010 ª2010 Elsevier Ltd All rights reservedwith a binding affinity (Ka) of 2 3 107
(Figure 5D). In order to observe the
gradually migration of HYL1/dsRNA com-
plex from a 1:1 ratio to 2:1 ratio, we con-
ducted EMSA using miR160/* as sub-
strate and used gradient gel ranging in
polyacrylamide concentration from 15%
to 3.5% to resolve the HYL1/dsRNA
complex (instead of 15% as we used for
other EMSA experiments). In this condi-
tion, we were able to observe complexshifts accompanying the increase of the HYL1 concentration
(Figures 5E and 5F). Taken together, our results suggest that
HYL1 dimer rather than monomer likely interacts with 21 nt
dsRNA.
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Figure 5. HYL1 Binds to dsRNA as a Dimer
(A) Size fractionation of multimerized HYL1 and
monomeric HYL1 without 21 nt dsRNA. Multimer-
ized HYL1 was eluted in high molecular fraction
around 440 kDa and monomeric HYL1 was placed
between 67 kDa and 43 kDa.
(B) HYL1 dimerization is enhanced by 21 nt
dsRNA. Addition of 1.1-fold of 21 nt dsRNA shifted
the elution peak of HYL1 to around 110 kDa. HYL1
monomer and HYL1 dimer are indicated.
(C) Molecular mass calculation aligned with the
molecular mass markers.
(D) ITC data of HYL1 binding to 21 nt (19 bp duplex)
dsRNA. Raw titration data and integrated heat
measurements are shown on the top and bottom
plots, respectively. The Kd and stoichiometry
numbers (n) obtained by fitting a standard two-
interaction-site model are shown with standard
deviation determined by nonlinear least-square
analysis. The n number automatically picked by
computer analysis was 0.48. The Kd value was
further recalculated by the fixation of n = 0.5 sup-
ported by crystal structure.
(E) Binding of full-length HYL1 to miRNA160/*
duplex resolving in gradient gel analysis.
Increasing protein concentrations of full-length
HYL1 (108 M to 8 3 108 M) were added to a
fixed amount of 21 nt (19 bp duplex) miRNA160/*
(2 3 108 M). RNA-Protein complex and free
RNA were annotated as RP and Rf, respectively.
(F) Bound HYL1 dimer and monomer were calcu-
lated from a plot of the fraction bound versus
protein concentration.
Structure
Structural insights into miRNA Processing by HYL1Next, we performed in vitro pull-down assays to confirm the
dimerization capacity of HR2. As expected, GST-HYL1 was
able to pull down HR2 but not HR1, whereas addition of 21 nt
(19 bp) miR172/* duplex increased the heterodimerization of
HYL1 and HR1+2, but an excessive amount of 21 nt (19 bp)
miR172/* duplex disrupted their interaction (Figure 6A). These
results suggest that an appropriate ratio of dsRNA to protein
may facilitate and strengthen HYL1 dimerization. To see whether
the heterodimeric interaction can be recapitulated in vivo, we
performed coimmunoprecipitation experiments using extracts
prepared from plants overexpressing 6Myc-HR1+2. Our results
show that the HYL1 antibody indeed detected a band in the im-
munocomplex containing 6Myc-HR1+2 and the immunocom-
plex also contained miRNA precursors (Figure 6B).
To investigate whether HYL1 forms a dimer in vivo, we used
HYL1 antibody to detect HYL1 from the total protein extract of
Arabidopsis using different buffer conditions and different
extraction procedures. Surprisingly, we were able to detect
both HYL1 dimer and monomer using buffer without the additionStructure 18, 594–605, May 12, 2010of SDS and Urea. In contrast, we were
only able to detect HYL1 monomer using
the buffer in the presence of SDS and
Urea (Figure 6C). Moreover, we made
a transgenic HA-SERRATE overexpres-
sion line to coimmunoprecipitation HYL1
and we were only able to detect HYL1
monomer after extensively washing thecoimmunoprecipitation samples with 0.5 M NaCl (Figure 6C).
These data suggest that probably additional RNA/protein factors
are required for HYL1 dimerization in vivo and strongly support
the notion that dsRNA enhances the dimerization of HYL1
in vitro.
DISCUSSION
Proposed Roles of HYL1 in Pri- and Pre-miRNA
Processing
Genetic and molecular analyses have shown that accurate pro-
cessing of pri- and pre-miRNAs in Arabidopsis is mediated by
a protein complex composed of at least three subunits, DCL1,
HYL1, and SE (reviewed by Chen, 2008). As a member of the
RNase III family, DCL1 can be safely assumed to play a central
role in precursor cleavage, but the precise roles of the other
two subunits are poorly understood in molecular terms. There-
fore, crystal structures supplemented with functional analysis
will pave the way to uncovering the molecular mechanisms onª2010 Elsevier Ltd All rights reserved 601
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Figure 6. HYL1 Forms Dimer In Vivo
(A) HYL1 interacts with HR1+2 in vitro. (Top)
dsRNA miR172/* duplex induces HYL1 and
HR1+2 interaction. 0.2 mM of GST-HYL1 was
used as bait and incubated with 0.2 mM of
HR1+2 and the indicated amount of miR172/*.
(Bottom) HR2 domain is responsible for HYL1
dimerization. 0.4 mM of HR1 or HR2 were incu-
bated with 0.2 mM of GST-HYL1 to identify the
interaction domain. The amounts of HR1+2, HR1,
and HR2 proteins are shown on the INPUT panel.
After incubation, GST-HYL1 was retrieved using
glutathione beads and pulled down proteins
were detected by western blots using antibodies
to HYL1.
(B) HYL1 interacts with HR1+2 in vivo. Coimmuno-
precipitation of 6Myc-HR1+2 with endogenous
HYL1. Seedlings of WT-expressing 35S-6Myc-
HR1+2 transgene were used for in vivo interaction
analysis. Extracts were treated with anti-Myc anti-
body and agarose-protein A (50 ml) to immunopre-
cipitate 6Myc-HR1+2. The immunoprecipitates
were analyzed with anti-HYL1 antibody to detect
the presence of endogenous HYL1. The non-ex-
pressing transgenic WT/35S-6Myc-HR1+2 #1
line was used as a negative control for coimmuno-
precipitation. RNA extracted from immunoprecip-
itated complex was amplified by PCR using
specific primers to miRNA166 and miRNA172
precursors.
(C) HYL1 forms dimer in vivo. (Lane 1) Total Arabi-
dopsis protein extracts from HA-SERRATE over-
expression lines were treated by ‘‘denatured’’
buffer and detected by anti-HYL1 poly-antibody.
(Lane 2) Total Arabidopsis protein extracts from
HA-SERRATE overexpression lines were treated
by ‘‘native’’ buffer and detected by anti-HYL1
poly-antibody. (Lane 3) Total Arabidopsis protein
extracts from lane 2 were treated with anti-HA
antibody and agarose-protein A (50 ml) to immuno-
precipitate endogenous HYL1. The immunopre-
cipitates were analyzed with anti-HYL1 antibody.
Structure
Structural insights into miRNA Processing by HYL1miRNA processing (reviewed by Zhu, 2008). Our structural and
biochemical analyses on HYL1 shed light on several key features
of dsRNA binding and recognition by HYL1. (a) The canonical
HR1 shows structural and functional similarity to the canonical
TR2 domain of TRBP2 in recognizing dsRNA both in vitro and
in vivo. (b) HYL1 forms a functional dimer and the dimerization
is probably mediated by HR2 domain. (c) HYL1 recognizes
dsRNA in a geometry-dependent but sequence-independent
manner. (d) The combination of canonical and noncanonical
dsRBDs in tandem is probably the conserved feature for facili-
tating miRNA processing.
We favor the view that HYL1 may scan through the dsRNA
stem portion of miRNA precursors and preferentially binds to
the miRNA/miRNA* region. At this moment, we do not know
how SE recognizes and enhances the accuracy of pri-miRNA
processing. However, HYL1 and SE may work cooperatively as
a molecular ruler to recruit DCL1 for pri- and pre-miRNA pro-
cessing (Figure S5). This working model of HYL1 is consistent
with the recent observation that HYL1 and SE together promote
accurate processing of pri-miRNA by DCL1 in vitro (Dong et al.,602 Structure 18, 594–605, May 12, 2010 ª2010 Elsevier Ltd All right2008) and the report that hyl1-2mutant instead of dcl1-7 or dcl1-
9mutant displays off-target pri-miRNA cleavage in vivo (Kurihara
et al., 2006). This observation further suggests that HYL1 prob-
ably binds and protects miRNA/miRNA* region from random
slicing by DCL1. A major challenge in the future is to incorporate
the important functions of SE and other components of miRNA
processing machinery such as DAWDLE (DDL) (Yu et al., 2008)
into this model.
Note Added
During the preparation of thismanuscript, Tagami et al. (2009) re-
ported that an amino acid substitution of Glu-395 with Lys in the
ATPase/DExH-box RNA helicase domain confers restoration of
miRNA expression in the hyl1-2 mutant background (Tagami
et al., 2009). This surprising result of the dominant dcl1-13
mutant seems to imply that HYL1may not be required for miRNA
processing. It is known that the cleavage activity of human Dicer
is repressed by its helicase domain and this autoinhibition can be
relieved by interaction with TRBP2, which triggers a structural
rearrangement of Dicer (Ma et al., 2008). We hypothesize thats reserved
Structure
Structural insights into miRNA Processing by HYL1a similar situation may apply to the HYL1/DCL1 interaction.
HYL1 may have two related functions in miRNA processing. In
addition to sensing and protecting the miRNA/miRNA* region
within a pri- and pre-miRNA, it may activate the RNase III domain
of DCL1 by mediating a structural rearrangement of the latter.
EXPERIMENTAL PROCEDURES
Construction of Escherichia coli Expression Vectors and Protein
Purification
cDNA encoding full-length HYL1 was cloned in frame into pET29a upstream of
DNA sequence encoding 6 histidine. cDNA sequences encoding HYL1
dsRBD1 (HR1; residues 15–84), HYL1 dsRBD2 (HR2; residues 100–172),
HYL1 dsRBD1+2 (HR1+2; residues 15–172), HYL1 dsRBD1+2+H (HR1+2+H;
residues 15–220), and TRBP2 dsRBD2 (TR2; residues 152–227) were cloned
into pET28b downstream of DNA sequences encoding 6 histidine. Chimeric
cDNA encoding TRBP2 dsRBD2+HYL1 dsRBD2 (TR2+HR2) was generated
by fusing the TRBP2 dsRBD2 (TR2) gene (amplified by primers chimeric-s1
and chimeric-as1 described in Table S1) and the HYL1 dsRBD2 (HR2) gene
(amplified by primers chimeric-s2 and chimeric-as2) by overlapping PCR
and cloned into pET28b downstream of DNA sequence encoding 6 histidine.
The fusion gene encoding glutathionin-S-transferase (GST) fused to HYL1
was prepared using pGEX-4T-1 vector. Mutants of full-length HYL1 were
prepared using the QuikChange Site-Directed Mutagenesis Kit (Stratagene)
and the constructs were verified by sequencing.
For protein expression, transformed E. coli cells were grown to an OD600 of
0.6 and induced overnight at 20C using 0.4 mM isopropyl b-d-thiogalacto-
side. After centrifugation, cells were resuspended in 1 mM EDTA, 1 mM dithio-
threitol (DTT), complete proteinase inhibitor (Roche), 1.0 M NaCl, and 50 mM
Tris (pH 7.4) and lysed by cell disruptor. After centrifugation (40,000 3 g,
1 hr), the supernatant was loaded onto a Ni2+ affinity column that was
equilibrated in 50 mM Tris (pH 7.6) with 500 mM NaCl. Nonspecific-binding
proteins were washed out by the same buffer with 25 mM imidazole, and
specific-binding protein was eluted with 250 mM imidazole in the same buffer.
Pooled fractions from the Ni2+ affinity column were concentrated and then
purified on a HiLoad Superdex S-75 26/60 column (Amersham) equilibrated
in 500 mM NaCl, 10 mM DTT, and 25 mM Tris (pH 7.4). The purified protein
was concentrated to 10 mg/ml in a Microcon (Amicon) and then dialyzed
against 50 mM NaCl. 21 nt RNA oligoribonucleotides were purchased from
Dharmacon. GST-fused HYL1 was purified with glutathione Sepharose resin
(GE Healthcare).
Crystallization and Data Collection
Crystals of HR1, HR2, HR1/dsRNA complex, and TR2/dsRNA complex were
grown by hanging drop vapor diffusion at 20C. Typically, a 2 ml hanging
drop contained 1.0 ml of protein or protein-RNA complex (0.4 mM) mixed
with 1.0 ml of reservoir solution and equilibrated over 1 ml of reservoir solution.
HR1 crystals grew to a maximum size of 0.20 mm3 0.10 mm3 0.10 mm over
the course of 2 days under the crystallization condition of 35%PEG 400, 0.2 M
magnesium chloride, and 100 mM HEPES (pH 7.5). HR2 crystals grew to
a maximum size of 0.15 mm 3 0.02 mm 3 0.02 mm over the course of
14 days under the crystallization condition of 28% PEG 400, 0.2 M calcium
chloride, and 100mM HEPES (pH 7.5). HR1/dsRNA complex was prepared
by annealing RNA1 and RNA2 first and then incubating the RNA duplex with
HR1 for 20 min before crystallization. The HR1/dsRNA complex crystals
grew to a maximum size of 0.15 mm 3 0.02 mm 3 0.02 mm over the course
of 3 days under the crystallization condition of 30% PEG 8000, 0.2 M ammo-
nium sulfate, and 100 mM sodium cacodylate (pH 7.5). TR2/dsRNA complex
was prepared by incubating GC10 RNAwith TRBP2 dsRBD2 for 20 min before
crystallization. TR2/dsRNA complex crystals grew to a maximum size of
0.15 mm 3 0.05 mm 3 0.05 mm over the course of 2 days under the crystal-
lization condition of 2.0 M ammonium sulfate, 10 mM magnesium sulfate, and
0.05M sodium cacodylate (pH 6.5).
For data collection, crystals were flash frozen (100 K) in the above reservoir
solution (HR1) or had increased PEG 400 to 35% (HR2) or were supplemented
with 30% glycerol (HR1/dsRNA and TR2/dsRNA). HR1 data, HR2 data, and
HR1/dsRNA data were collected at 1.5418 A˚ on our in-house Rigaku diffrac-Structure 18,tometer. A total of 150 frames of 1 oscillation were collected for HR1; a
total of 180 frames of 1 oscillation were collected for HR2; a total of
180 frames of 1 oscillation were collected for HR1/dsRNA. TR2 data set
was collected at 1.1A˚ on beamline X12C at the National Synchrotron Light
Source at Brookhaven National Laboratory. A total of 360 frames of 1 oscilla-
tion were collected. All data sets were processed by HKL2000 (www.hkl-xray.
com). The crystals belonging to space group P212121 (HR1), P43 (HR2), P43
(HR1/dsRNA), and I212121 (TR2/dsRNA) with unit cell parameters are listed
in Table 1.
Structure Determination
Crystal structures of HR1, HR2, HR1/dsRNA complex, and TR2/dsRNA
complex were determined by molecular replacement using the crystal struc-
ture of the second dsRBD of Xenopus laevis RNA-binding protein A as the
search model (PDBID: 1DI2). Models were rebuilt by using the program O
(Jones et al., 1991) and refined using REFMAC/CCP4 (CCP4, 1994) with
Rwork = 20.7% and Rfree = 25.4% (HR1), Rwork = 25.5% and Rfree = 32.2%
(HR2), Rwork = 20.4% and Rfree = 31.7% (HR1/dsRNA complex), and Rwork =
26.1% and Rfree = 29.8% (TR2/dsRNA complex). The R free set contained
5% or 10% (HR2) of the reflections chosen at random.
Plant Material, Growth Conditions, and Generation of Transgenic
Plants
The hyl1-2 (SALK_064863) mutant and all transgenic lines used are in the Col-
0 background. Sterilized seeds were germinated on MS medium with 1%
sucrose. After 4 days of incubation in darkness at 4C, seeds were incubated
at 22C under long day light condition. Plants were transformed by Agrobac-
terium (EHA105 strain)-mediated infiltration using the floral dip method
(Clough and Bent, 1998; Zhang et al., 2006a).
Production of Overexpression Lines
35S-HYL1-6Myc, 35S-6Myc-HR1+2, and 35S-3HA-TR2+HR2 transgenes
were constructed using pBA002-6myc and pBA002-3HA binary vectors.
PCR product for HR1+2 DNA fragment was generated by XhoIHYL1 dsRBD-
s and AscIHYL1 dsRBD2-as primers and inserted into pBA002-6myc binary
vectors. 35S-HA-SERRATE transgene was constructed using pBA002-3HA
binary vector. For construction of the TR2+HR2 chimeric gene, the chimeric
DNA fragment used for protein expression was amplified by AvrIIHYL1
dsRBD1 s and PacIHYL1 dsRBD2-as primers and subcloned into pBA002-
3HA binary vector (Table S1). Constructs were transferred into WT or hyl1-2
mutant to generate hyl1-2/35S-HYL1-6Myc, WT/35S-6Myc-HR1+2, hyl1-2/
35S-6Myc-HR1+2, and hyl1-2/35S-3HA-TR2+HR2 transgenic lines.
RNA Extraction, RT-PCR, QRT-PCR, and Northern Blot Hybridization
Total RNA was extracted from Arabidopsis seedlings using RNeasy Plant Mini
kits (QIAGENe) or Trisol reagent (Invitrogen). Reverse transcription was per-
formed using Ready-To-go You Prime First Strand Beads (GE Healthcare) or
MMLV reverse transcriptase system (Promega) according to the manufac-
turer’s instruction. QRT-PCR was performed with Applied Biosystems
7900HT real-time PCR system using the oligonucleotides described in
Table S1. Relative amounts of target genes were calculated by the formula
2(DDCT), where CT was the cycle number at which the fluorescence reached
the threshold point for detection. All calculations were calibrated by ACTIN
threshold cycles with three individual replicates to reduce loading errors.
MiRNA northern blot analysis was performed as described in Zhang et al.
(2006b) using complementary DNA sequences for miR159, miR160, miR164,
miR166, and miR172 (Table S1). For western blot analysis, seedlings were
ground with Tissuelyzer (QIAGENe) in 63 SDS-sample buffer for 1 min.
Samples were then incubated at 100C for 10 min and extracts were resolved
on 10% SDS-PAGE gels. Blots were detected with anti-HYL1 antibodies and
anti-tubulin antibodies.
Gel Shift Mobility Assays
32P-UTP-labeled pri-miRNA164b RNA and pre-miRNA164b probes were
produced by in vitro transcription kits (Ambion) following the manufacturer’s
instructions. Short RNA probes for gel mobility shift assay were labeled with
32P-ATP and the sequences were given in Table S1. Concentration of RNA
probes and proteins are described in the figure legends. Reaction mixtures594–605, May 12, 2010 ª2010 Elsevier Ltd All rights reserved 603
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(pH 8.0)-buffered 4%–15% polyacrylamide gel with Tris-Cl (pH 7.4–8.0)-
buffered 4%–8% stacking polyacrylamide gel at 4C or 22C. To compare
the binding affinity among different deletion constructs, a fixed amount of
21 nt (19 bp duplex) miRNA160/* (2 3 108M) probes was titrated with
increasing amount of proteins: HYL1 (5 3 109 M to 3.2 3 107 M), HR1+2
(1 3 108 M to 5.5 3 107 M), TR2+HR2 (1 3 108 M to 5.5 3 107 M),
and HR1 (2 3 107 M to 6 3 105 M). Data were analyzed using the equation
[RNAbound]/[RNAtotal] = [Protein]/(Kd +[Protein]) and apparent dissociation
constants were calculated by fitting the saturation hyperbola graphs from
fraction bound (F) versus protein concentration (P), where F = [RNAbound]/
[RNAtotal].
In Vitro Pull-Down Assays
GST-HYL1 fusion protein (2 3 107M) was applied to 1 ml of binding buffer
[50 mM Tris-HCl (pH 7.4), 100 mM NaCl, 0.6% Triton X-100, and 50 U/ml
RNAsin] with HR1+2 (2 3 107 M), HR11-100(4 3 107 M), and HR2101-171
(4 3 107 M) and incubated with or without 21 nt (19 bp duplex) miRNA172/*
(0 to 4 3 107 M). Reaction mixtures were incubated with 30 ml of 70% gluta-
thione-S-transferase bead at 4C for 2 hr and extensively washed with binding
buffer containing 1% Triton X-100. Samples were boiled at 100C with
63 SDS-sample buffer and resolved by 8% of SDS-PAGE. Resolved proteins
were transferred to PVDF membrane and western blots were analyzed using
anti-HYL1 antibody.
HYL1 Dimer Detection In Vivo
The flower clusters (0.1g) were collected from HA-SERRATE overexpression
line 5–7 weeks old, frozen in liquid nitrogen, and homogenized in 0.7 ml of
‘‘native’’ buffer [25 mM Tris (pH 7.4), 25 mM potassium phosphate (pH 6.8),
500 mM NaCl, 10% glycerol, and 1 mM DTT] supplemented with 2% b-mer-
captoethanol and proteinase inhibitor cocktail or ‘‘denatured’’ buffer [50 mM
Tris (pH 6.8), 4.5% SDS, 7.5% b-mercaptoethanol, and 9 M Urea], respec-
tively. After separation from insoluble fractions by centrifuge, the extract
was incubated with EZview Red anti-HA Affinity Gel (Sigma-Aldrich) for 1 hr
at 4C, washed with ‘‘native’’ buffer, and eluted as described in the manufac-
turer’s instructions. The eluent was resolved by 12%SDS-PAGE and detected
by western blot using polyclonal antibodies raised in rabbit against SERRATE
and HYL1.
Coimmunoprecipitation of Pri-miRNA and Pre-miRNA
WT (Col-0), hyl1-2, dcl1-9, se1, and hyl1-2/35S-3HA-TR2+HR2 lines were sub-
jected to in vivo crosslinking and immunoprecipitation using the modified
method of Song et al. (2007). Coimmunoprecipitated pri-miRNAs and pre-
miRNAs were detected by PCR using primers in Table S1. Coimmunoprecipi-
tation of endogenous HYL1 was performed with WT/35S-6Myc-HR1+HR2
lines as described by Jang et al. (2007).
Analytical Gel Filtration
Full-length HYL1 protein and protein-RNA complexes were analyzed on
a Superdex 200 10/300 GL column with a flow rate of 0.5 ml/min with an injec-
tion volume of 0.1 ml. All experiments were performed in a buffer of 25 mM
Tris-HCl and 100 mM NaCl (pH 7.4). For the complex, HYL1 was incubated
with 21 nt dsRNA duplex at a molar ratio of (1:1.1) on ice for 1 hr. The column
was first calibrated with the high molecular weight gel filtration kit (GE Health-
care) and the corresponding curves were established by OriginPro 7.5.
Isothermal Titration Calorimetry Assay
All experiments were performed in a buffer containing 12.5 mM Tris-HCl
(pH 7.4) and 100 mM NaCl. Full-length HYL1 (20 mM) and 21 nt (19 bp duplex)
dsRNA duplex (200 mM) samples were filtered and degassed before titration.
Protein sample was loaded into the cell and RNA sample was loaded into
the syringe with a stirring speed of 310 rpm (Microcal VP-ITC calorimeter).
Data were collected in the high feedback mode with a filter period of 3 s.
The calorimetric data were processed and fitted into the single set of identical
sites model using Microcal Origin (Version 5.0) and analyzed by the software
supplied by the instrument.604 Structure 18, 594–605, May 12, 2010 ª2010 Elsevier Ltd All rightACCESSION NUMBERS
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